163 related articles for article (PubMed ID: 7880725)
1. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.
Enomoto T; Fujita M; Cheng C; Nakashima R; Ozaki M; Inoue M; Nomura T
Br J Cancer; 1995 Mar; 71(3):462-7. PubMed ID: 7880725
[TBL] [Abstract][Full Text] [Related]
2. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
3. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression.
Saegusa M; Machida D; Okayasu I
Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668
[TBL] [Abstract][Full Text] [Related]
4. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma].
Li PL; Liu MM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365
[TBL] [Abstract][Full Text] [Related]
5. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.
Schmitt CA; Thaler KR; Wittig BM; Kaulen H; Meyer zum Büschenfelde KH; Dippold WG
Br J Cancer; 1998 Feb; 77(4):588-94. PubMed ID: 9484816
[TBL] [Abstract][Full Text] [Related]
6. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
Zhang J; Ding F; Wang X
Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
[TBL] [Abstract][Full Text] [Related]
7. Frequent reduction or loss of DCC gene expression in human osteosarcoma.
Horstmann MA; Pösl M; Scholz RB; Anderegg B; Simon P; Baumgaertl K; Delling G; Kabisch H
Br J Cancer; 1997; 75(9):1309-17. PubMed ID: 9155051
[TBL] [Abstract][Full Text] [Related]
8. DCC gene alteration in human endometrial carcinomas.
Gima T; Kato H; Honda T; Imamura T; Sasazuki T; Wake N
Int J Cancer; 1994 May; 57(4):480-5. PubMed ID: 7514150
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma.
Saegusa M; Hashimura M; Hara A; Okayasu I
Cancer; 1999 Jan; 85(2):453-64. PubMed ID: 10023715
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.
Iino H; Fukayama M; Maeda Y; Koike M; Mori T; Takahashi T; Kikuchi-Yanoshita R; Miyaki M; Mizuno S; Watanabe S
Cancer; 1994 Mar; 73(5):1324-31. PubMed ID: 7906606
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma.
Kashiwaba M; Tamura G; Ishida M
Virchows Arch; 1995; 426(5):441-6. PubMed ID: 7633654
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer.
Sturlan S; Kapitanović S; Kovacević D; Lukac J; Spaventi S; Spaventi R; Pavelić K
J Mol Med (Berl); 1999 Mar; 77(3):316-21. PubMed ID: 10090594
[TBL] [Abstract][Full Text] [Related]
14. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
15. The DCC gene product in cellular differentiation and colorectal tumorigenesis.
Hedrick L; Cho KR; Fearon ER; Wu TC; Kinzler KW; Vogelstein B
Genes Dev; 1994 May; 8(10):1174-83. PubMed ID: 7926722
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
[TBL] [Abstract][Full Text] [Related]
17. Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant.
Yoshida Y; Itoh F; Endo T; Hinoda Y; Imai K
Int J Cancer; 1998 Dec; 79(6):634-9. PubMed ID: 9842974
[TBL] [Abstract][Full Text] [Related]
18. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
19. Suppression of endometrial carcinoma cell tumorigenicity by human chromosome 18.
Yamada H; Sasaki M; Honda T; Wake N; Boyd J; Oshimura M; Barrett JC
Genes Chromosomes Cancer; 1995 May; 13(1):18-24. PubMed ID: 7541639
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma.
Younes A; Zhao S; Jendiroba D; Kleine HD; Cabanillas F; Andreeff M
Blood; 1995 May; 85(10):2813-6. PubMed ID: 7742542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
